Cargando…
Risk for cognitive impairment among HIV-infected persons with bipolar disorder
Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infect...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181874/ |
_version_ | 1782212831710543872 |
---|---|
author | Moore, David J. Depp, Colin A. Posada, Carolina Parikh, Mili Bhatt, Archana Moseley, Suzanne Vigil MS, Ofilio Everall, Ian P. Atkinson, J. Hampton Grant, Igor HNRC Group, |
author_facet | Moore, David J. Depp, Colin A. Posada, Carolina Parikh, Mili Bhatt, Archana Moseley, Suzanne Vigil MS, Ofilio Everall, Ian P. Atkinson, J. Hampton Grant, Igor HNRC Group, |
author_sort | Moore, David J. |
collection | PubMed |
description | Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infection appears to be more prevalent among persons with bipolar disorder and that both conditions pose significant risk for cognitive impairment.(3) Higher rates of HIV infection among persons with bipolar disorder should not be surprising, given that infection and transmission of HIV involves risk factors that converge with bipolar disorder (eg, impulsivity, substance abuse). These factors likely also worsen adherence to treatment for both bipolar and HIV illness, and may adversely impact health-related quality of life and therapeutic outcomes. The public health consequence may be that nonadherence to antiretroviral therapy could lead to higher rates of transmission of treatment-resistant strains of HIV that can evolve with sporadic adherence. The intersection of bipolar disorder and HIV therefore merits discussion by clinicians, researchers, and policy makers. |
format | Online Article Text |
id | pubmed-3181874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31818742011-10-27 Risk for cognitive impairment among HIV-infected persons with bipolar disorder Moore, David J. Depp, Colin A. Posada, Carolina Parikh, Mili Bhatt, Archana Moseley, Suzanne Vigil MS, Ofilio Everall, Ian P. Atkinson, J. Hampton Grant, Igor HNRC Group, Dialogues Clin Neurosci Poster Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infection appears to be more prevalent among persons with bipolar disorder and that both conditions pose significant risk for cognitive impairment.(3) Higher rates of HIV infection among persons with bipolar disorder should not be surprising, given that infection and transmission of HIV involves risk factors that converge with bipolar disorder (eg, impulsivity, substance abuse). These factors likely also worsen adherence to treatment for both bipolar and HIV illness, and may adversely impact health-related quality of life and therapeutic outcomes. The public health consequence may be that nonadherence to antiretroviral therapy could lead to higher rates of transmission of treatment-resistant strains of HIV that can evolve with sporadic adherence. The intersection of bipolar disorder and HIV therefore merits discussion by clinicians, researchers, and policy makers. Les Laboratoires Servier 2008-06 /pmc/articles/PMC3181874/ Text en Copyright: © 2008 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Moore, David J. Depp, Colin A. Posada, Carolina Parikh, Mili Bhatt, Archana Moseley, Suzanne Vigil MS, Ofilio Everall, Ian P. Atkinson, J. Hampton Grant, Igor HNRC Group, Risk for cognitive impairment among HIV-infected persons with bipolar disorder |
title | Risk for cognitive impairment among HIV-infected persons with bipolar disorder
|
title_full | Risk for cognitive impairment among HIV-infected persons with bipolar disorder
|
title_fullStr | Risk for cognitive impairment among HIV-infected persons with bipolar disorder
|
title_full_unstemmed | Risk for cognitive impairment among HIV-infected persons with bipolar disorder
|
title_short | Risk for cognitive impairment among HIV-infected persons with bipolar disorder
|
title_sort | risk for cognitive impairment among hiv-infected persons with bipolar disorder |
topic | Poster |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181874/ |
work_keys_str_mv | AT mooredavidj riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT deppcolina riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT posadacarolina riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT parikhmili riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT bhattarchana riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT moseleysuzanne riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT vigilmsofilio riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT everallianp riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT atkinsonjhampton riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT grantigor riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder AT hnrcgroup riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder |